Nutraceutical helps patient see clearly

Article

Longevinex (Resveratrol), a nutraceutical matrix, can remove lipofuscin deposits from the retina to improve visual acuity and night vision, according to research presented at this year's meeting of the American Academy of Optometry in Seattle, US.

Longevinex (Resveratrol), a nutraceutical matrix, can remove lipofuscin deposits from the retina to improve visual acuity and night vision, according to research presented at this year's meeting of the American Academy of Optometry in Seattle, US.

Stuart Richer, OD, PhD, FAAO, Chief of the Optometry Section at the Veterans Medical Center in North Chicago, US and colleagues treated a male patient (aged 80 years) with nutraceuticals to improve his night vision. No improvement was observed. After five months of treatment with the Longevinex supplement, which removes excess minerals (including calcium, iron and copper) through chelation, the subject showed a statistically significant increase in night vision, visual acuity, side vision and colour perception.

Although Dr Richer concedes that Longevinex is not yet ready to be marketed as a treatment, the results so far have been positive and there have been no side effects.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.